Perfil
David Nakasone is Senior Director-Investor Relations at Tarsus Pharmaceuticals, Inc. since 2021.
Formerly, Mr. Nakasone was Director-Investor Relations at Lineage Cell Therapeutics, Inc., Associate Director-Investor Relations at Ionis Pharmaceuticals, Inc., and Investor Relations Contact at Allergan, Inc. from 2013 to 2015.
Education includes undergraduate studies at San Diego State University.
Cargos activos de David Nakasone
| Empresas | Cargo | Inicio |
|---|---|---|
| TARSUS PHARMACEUTICALS, INC. | Contacto de Relaciones con Inversores | 01/09/2021 |
Antiguos cargos conocidos de David Nakasone.
| Empresas | Cargo | Fin |
|---|---|---|
| ALLERGAN, INC. | Public Communications Contact | 01/06/2015 |
| IONIS PHARMACEUTICALS, INC. | Public Communications Contact | - |
| LINEAGE CELL THERAPEUTICS, INC. | Contacto de Relaciones con Inversores | - |
Formación de David Nakasone.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapeutic drugs for blepharitis | Health Technology |
- Bolsa de valores
- Insiders
- David Nakasone
















